Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -23.52% | 12.94% | 39.68% | -112.76% | -31.08% |
| Total Depreciation and Amortization | -4.63% | -39.54% | -54.90% | 20.29% | 6.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.48% | -26.79% | -15.65% | 751.72% | 17.02% |
| Change in Net Operating Assets | 4.72% | 402.42% | 44.88% | -384.99% | -80.97% |
| Cash from Operations | -1.52% | 58.22% | 52.48% | -95.07% | -258.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -52.40% | -81.52% | -88.31% | -20.94% |
| Total Debt Repaid | -140.10% | -243.64% | 32.17% | 89.90% | 55.25% |
| Issuance of Common Stock | 53.72% | -46.77% | -55.35% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.29% | -61.90% | -55.97% | 105.69% | 75.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.84% | 14.20% | -826.32% | 86.08% | -121.33% |
